{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:28:30Z","timestamp":1776821310928,"version":"3.51.2"},"reference-count":65,"publisher":"JLE","issue":"1","content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.nephro.2013.11.005","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T00:16:12Z","timestamp":1388708172000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Syndrome h\u00e9pator\u00e9nal"],"prefix":"10.1684","volume":"10","author":[{"given":"\u00c9vang\u00e9line","family":"Pillebout","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2013.11.005_bib0005","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gines","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.11.005_bib0010","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gines","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2013.11.005_bib0015","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2215\/CJN.01340406","article-title":"Hepatorenal syndrome: pathophysiology and management","volume":"1","author":"Wadei","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2013.11.005_bib0020","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl. 3","key":"10.1016\/j.nephro.2013.11.005_bib0030","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1097\/MCG.0b013e3181468b4c","article-title":"The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension","volume":"41","author":"Iwakiri","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.nephro.2013.11.005_bib0035","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.20632","article-title":"Bacterial translocation (BT) in cirrhosis","volume":"41","author":"Wiest","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0045","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1053\/gast.2002.33575","article-title":"Hepatorenal syndrome in cirrhosis: pathogenesis and treatment","volume":"122","author":"Arroyo","year":"2002","journal-title":"Gastroenterology"},{"issue":"2suppl. 1","key":"10.1016\/j.nephro.2013.11.005_bib0050","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/hep.20832","article-title":"Hepatorenal syndrome\u00a0\u2013\u00a0is it central hypovolemia, a cardiac disease, or part of gradually developing multiorgan dysfunction?","volume":"42","author":"Lenz","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0060","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/ki.2010.4","article-title":"Afferent mechanisms of sodium retention in cirrhosis and hepatorenal syndrome","volume":"77","author":"Oliver","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.11.005_bib0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0070","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2013.11.005_bib0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archinte.1994.00420020117013","article-title":"Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis","volume":"154","author":"Caregaro","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nephro.2013.11.005_bib0080","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/ndt\/gfh839","article-title":"Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis","volume":"20","author":"Proulx","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2013.11.005_bib0085","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1053\/j.ajkd.2003.08.017","article-title":"Prediction of GFR in liver transplant candidates","volume":"42","author":"Skluzacek","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.11.005_bib0090","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1111\/j.1572-0241.2005.00271.x","article-title":"Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study","volume":"100","author":"Peron","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.nephro.2013.11.005_bib0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5414\/CNP65028","article-title":"Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis","volume":"65","author":"Wu","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2013.11.005_bib0100","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0110","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0115","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1\u00a0hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1523-1755.2005.00408.x","article-title":"Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy","volume":"68","author":"Wong","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.11.005_bib0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jhep.2003.50084","article-title":"Acute renal failure in patients with cirrhosis: perspectives in the age of MELD","volume":"37","author":"Moreau","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0130","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/jhep.2002.33160","article-title":"Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation","volume":"35","author":"Nair","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0135","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0145","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0150","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2007.02.001","article-title":"Advances in the pathogenesis and treatment of type-1\u00a0and type-2\u00a0hepatorenal syndrome","volume":"46","author":"Arroyo","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.11.005_bib0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2008-1040323","article-title":"Pathogenesis and treatment of hepatorenal syndrome","volume":"28","author":"Arroyo","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.nephro.2013.11.005_bib0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/08860229509026250","article-title":"Risk factors and outcome of 107\u00a0patients with decompensated liver disease and acute renal failure (including 26\u00a0patients with hepatorenal syndrome): the role of hemodialysis","volume":"17","author":"Keller","year":"1995","journal-title":"Ren Fail"},{"key":"10.1016\/j.nephro.2013.11.005_bib0165","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","article-title":"Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club","volume":"32","author":"Rimola","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.11.005_bib0170","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1681\/ASN.V1081833","article-title":"Hepatorenal syndrome","volume":"10","author":"Gines","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"4Pt1","key":"10.1016\/j.nephro.2013.11.005_bib0175","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/jhep.2001.27830","article-title":"Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis","volume":"34","author":"Cardenas","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0180","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00007890-199502150-00010","article-title":"Impact of pretransplant renal function on survival after liver transplantation","volume":"59","author":"Gonwa","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2013.11.005_bib0185","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1111\/j.1600-6143.2006.01526.x","article-title":"Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?","volume":"6","author":"Gonwa","year":"2006","journal-title":"Am J Transplant"},{"issue":"4\u00a0Pt 1","key":"10.1016\/j.nephro.2013.11.005_bib0190","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, non-randomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","article-title":"Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion","volume":"27","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0200","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.3748\/wjg.v16.i41.5139","article-title":"Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists","volume":"16","author":"Magan","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nephro.2013.11.005_bib0205","first-page":"CD005162","article-title":"Terlipressin for hepatorenal syndrome","volume":"4","author":"Gluud","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nephro.2013.11.005_bib0210","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Martin-Llahi","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0215","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1\u00a0hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0220","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1440-1746.2002.02816.x","article-title":"Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1\u00a0hepatorenal syndrome treated with terlipressin: a retrospective analysis","volume":"17","author":"Colle","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.nephro.2013.11.005_bib0225","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jhep.2003.50276","article-title":"Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study","volume":"38","author":"Pomier-Layrargues","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0230","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1440-1746.2005.03902.x","article-title":"Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis","volume":"20","author":"Kalambokis","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.nephro.2013.11.005_bib0235","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1\u00a0hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0240","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1\u00a0hepatorenal syndrome","volume":"52","author":"Esrailian","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.nephro.2013.11.005_bib0245","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"issue":"9053","key":"10.1016\/j.nephro.2013.11.005_bib0250","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(97)24010-9","article-title":"Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome","volume":"349","author":"Brensing","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2013.11.005_bib0255","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0260","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2013.11.005_bib0265","doi-asserted-by":"crossref","first-page":"374","DOI":"10.5414\/CNP62374","article-title":"Ascites reinfusion dialysis (ARD) for renal failure with refractory ascites","volume":"62","author":"McGill","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2013.11.005_bib0270","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0016-5085(61)80132-7","article-title":"Effects of ascitic fluid infusion on sodium excretion, blood volume, and creatinine clearance in cirrhosis","volume":"40","author":"Yamahiro","year":"1961","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0275","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MAT.0b013e3181b37d86","article-title":"Albumin dialysis MARS: knowledge from 10\u00a0years of clinical investigation","volume":"55","author":"Mitzner","year":"2009","journal-title":"ASAIO J"},{"key":"10.1016\/j.nephro.2013.11.005_bib0280","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"issue":"4Pt1","key":"10.1016\/j.nephro.2013.11.005_bib0285","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1053\/jhep.2002.36130","article-title":"Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study","volume":"36","author":"Heemann","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0290","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gut.2008.174615","article-title":"Molecular adsorbent recirculating system is ineffective in the management of type 1\u00a0hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2013.11.005_bib0295","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0168-8278(90)90106-2","article-title":"Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1\u00a0analogue) and albumin administration","volume":"11","author":"Fevery","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.11.005_bib0300","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0168-8278(90)90104-Y","article-title":"Prostaglandins and the treatment of hepatorenal syndrome in cirrhosis","volume":"11","author":"Arroyo","year":"1990","journal-title":"J Hepatol"},{"issue":"9149","key":"10.1016\/j.nephro.2013.11.005_bib0305","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(05)74933-3","article-title":"Improvement in renal function in hepatorenal syndrome with N-acetylcysteine","volume":"353","author":"Holt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2013.11.005_bib0310","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.11.005_bib0315","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.11.005_bib0320","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.11.005_bib0325","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","article-title":"Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone","volume":"110","author":"Mathurin","year":"1996","journal-title":"Gastroenterology"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725513006081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725513006081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2013.11.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:55:15Z","timestamp":1741186515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725513006081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1769725513006081"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2013.11.005","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndrome h\u00e9pator\u00e9nal","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2013.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Association Soci\u00e9t\u00e9 de n\u00e9phrologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}